1. Lamotrigine Induced DRESS Syndrome in a Child: A Case Report and Literature Review
- Author
-
I-Ching Chou, Sheng-Shing Lin, Chieh-Ho Chen, Syuan-Yu Hong, and Chien-Heng Lin
- Subjects
Drug ,medicine.medical_specialty ,media_common.quotation_subject ,medicine.medical_treatment ,Case Report ,Lamotrigine ,Pediatrics ,RJ1-570 ,Drug reaction with eosinophilia and systemic symptoms ,Epilepsy ,medicine ,DRESS syndrome ,media_common ,integumentary system ,business.industry ,dyspnea ,medicine.disease ,Dermatology ,Rash ,Discontinuation ,Anticonvulsant ,Pediatrics, Perinatology and Child Health ,Organ involvement ,lamotrigine ,medicine.symptom ,business ,human activities ,medicine.drug - Abstract
BackgroundLamotrigine is an important anticonvulsant drug. Its use, however, has been limited by the risk of potentially life-threatening dermatological reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS).Case presentationHere, we report the case of a 7-year-6-month-old girl with a history of epilepsy who developed a skin rash with dyspnoea after 2 weeks of lamotrigine treatment, with DRESS ultimately being diagnosed. After discontinuation of the offending drug and the initiation of systemic glucocorticosteroids, the DRESS symptoms were relieved and the patient was discharged in stable condition.ConclusionAnticonvulsant drugs such as lamotrigine among the factors that induce DRESS in children. When a patient displays skin rash and systemic organ involvement following the initiation of an anticonvulsant drug, DRESS should not be overlooked as a diagnosis, and immunosuppressant drugs should be considered as an option for treating DRESS patients.
- Published
- 2021
- Full Text
- View/download PDF